226 related articles for article (PubMed ID: 23573114)
1. Chimerism-based experimental models for tolerance induction in vascularized composite allografts: Cleveland clinic research experience.
Siemionow M; Klimczak A
Clin Dev Immunol; 2013; 2013():831410. PubMed ID: 23573114
[TBL] [Abstract][Full Text] [Related]
2. Vascularized osteomyocutaneous allografts are permissive to tolerance by induction-based immunomodulatory therapy.
Lin CH; Zhang W; Ng TW; Zhang D; Jiang J; Pulikkottil B; Lakkis F; Gorantla VS; Lee WP; Brandacher G; Zheng XX
Am J Transplant; 2013 Aug; 13(8):2161-8. PubMed ID: 23718897
[TBL] [Abstract][Full Text] [Related]
3. Advances in the development of experimental composite tissue transplantation models.
Siemionow M; Klimczak A
Transpl Int; 2010 Jan; 23(1):2-13. PubMed ID: 19719468
[TBL] [Abstract][Full Text] [Related]
4. Improving the safety of tolerance induction: chimerism and cellular co-treatment strategies applied to vascularized composite allografts.
Huang WC; Lin JY; Wallace CG; Wei FC; Liao SK
Clin Dev Immunol; 2012; 2012():107901. PubMed ID: 23118778
[TBL] [Abstract][Full Text] [Related]
5. Tolerance of a Vascularized Composite Allograft Achieved in MHC Class-I-mismatch Swine
Lellouch AG; Andrews AR; Saviane G; Ng ZY; Schol IM; Goutard M; Gama AR; Rosales IA; Colvin RB; Lantieri LA; Randolph MA; Benichou G; Cetrulo CL
Front Immunol; 2022; 13():829406. PubMed ID: 35619720
[TBL] [Abstract][Full Text] [Related]
6. Tolerance induction strategies in vascularized composite allotransplantation: mixed chimerism and novel developments.
Leonard DA; McGrouther DA; Kurtz JM; Cetrulo CL
Clin Dev Immunol; 2012; 2012():863264. PubMed ID: 23320020
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314
[TBL] [Abstract][Full Text] [Related]
8. The need for inducing tolerance in vascularized composite allotransplantation.
Ravindra KV; Xu H; Bozulic LD; Song DD; Ildstad ST
Clin Dev Immunol; 2012; 2012():438078. PubMed ID: 23251216
[TBL] [Abstract][Full Text] [Related]
9. Tolerance induction via mixed chimerism in vascularized composite allotransplantation: is it time for clinical application?
Cetrulo CL; Drijkoningen T; Sachs DH
Curr Opin Organ Transplant; 2015 Dec; 20(6):602-7. PubMed ID: 26536420
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
Chimerism; 2013; 4(1):20-2. PubMed ID: 23712382
[TBL] [Abstract][Full Text] [Related]
11. Donor Recipient Chimeric Cells Induce Chimerism and Extend Survival of Vascularized Composite Allografts.
Cwykiel J; Jundzill A; Klimczak A; Madajka-Niemeyer M; Siemionow M
Arch Immunol Ther Exp (Warsz); 2021 May; 69(1):13. PubMed ID: 33970329
[TBL] [Abstract][Full Text] [Related]
12. Stable mixed hematopoietic chimerism permits tolerance of vascularized composite allografts across a full major histocompatibility mismatch in swine.
Mathes DW; Solari MG; Gazelle GS; Butler PE; Wu A; Nazzal A; Nielsen GP; Huang CA; Sachs DH; Lee WP; Randolph MA
Transpl Int; 2014 Oct; 27(10):1086-96. PubMed ID: 24963743
[TBL] [Abstract][Full Text] [Related]
13. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
Chen B; Xu H; Corbin DR; Ildstad ST
Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
[TBL] [Abstract][Full Text] [Related]
14. Donor derived hematopoietic stem cell niche transplantation facilitates mixed chimerism mediated donor specific tolerance.
Zhang W; Wang Y; Zhong F; Wang X; Sucher R; Lin CH; Brandacher G; Solari MG; Gorantla VS; Zheng XX
Front Immunol; 2023; 14():1093302. PubMed ID: 36875068
[TBL] [Abstract][Full Text] [Related]
15. Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism.
Kawai T; Cosimi AB; Sachs DH
Curr Opin Organ Transplant; 2011 Aug; 16(4):366-71. PubMed ID: 21666482
[TBL] [Abstract][Full Text] [Related]
16. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
[TBL] [Abstract][Full Text] [Related]
17. A modified heterotopic swine hind limb transplant model for translational vascularized composite allotransplantation (VCA) research.
Ibrahim Z; Cooney DS; Shores JT; Sacks JM; Wimmers EG; Bonawitz SC; Gordon C; Ruben D; Schneeberger S; Lee WP; Brandacher G
J Vis Exp; 2013 Oct; (80):. PubMed ID: 24145603
[TBL] [Abstract][Full Text] [Related]
18. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
Colson YL; Zadach K; Nalesnik M; Ildstad ST
Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
[TBL] [Abstract][Full Text] [Related]
19. Intra-bone Bone Marrow Transplantation in Pig-to-Nonhuman Primates for the Induction of Tolerance Across Xenogeneic Barriers.
Yamada K; Ariyoshi Y; Pomposelli T; Takeuchi K
Methods Mol Biol; 2020; 2110():213-225. PubMed ID: 32002911
[TBL] [Abstract][Full Text] [Related]
20. Nonhuman primate models of transplant tolerance: closer to the holy grail.
Kitchens WH; Adams AB
Curr Opin Organ Transplant; 2016 Feb; 21(1):59-65. PubMed ID: 26709576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
